TherapeuticsMD (TXMD) Reports Q4 Loss of $0.10/Share

TherapeuticsMD (NYSE: TXMD) reported Q4 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $4.26 million, versus $2.86 million reported last year.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Freedom Broker Starts Copart (CPRT) at Buy
• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance